Dr Peter Presgrave

Professor Peter Presgrave is a highly regarded Consultant Haematologist based in Wollongong, Australia. He provides comprehensive care for patients experiencing a wide range of both malignant and non-malignant blood disorders. With a clinical focus that spans general and complex haematological conditions, Dr Presgrave is dedicated to delivering personalised, evidence-based treatment pathways. His clinical interests particularly lie in the management of blood cancers, including myeloma, lymphoma, and various forms of leukaemia, as well as overseeing bone marrow transplantation services.

Dr Presgrave completed his medical degree at the University of Sydney, graduating in 1982. He subsequently undertook extensive postgraduate training, culminating in dual fellowships with the Royal Australasian College of Physicians and the Royal College of Pathologists of Australasia. Demonstrating a strong commitment to academic excellence, he was awarded a National Health and Medical Research Council (NHMRC) Scholarship and completed a PhD focusing on gene therapy for chronic myeloid leukaemia. Dr Presgrave maintains active professional memberships with several prestigious organisations, including the Australasian Leukaemia and Lymphoma Group, the American Society of Haematology, and the European Haematology Association.

In addition to his clinical practice, Dr Presgrave is a prominent figure in medical research and clinical leadership. He serves in several senior leadership capacities, including as a Director of Clinical and Laboratory Haematology, Head of Haematology Clinical Trials, and Director of the Bone Marrow Transplant Service. As a passionate advocate for clinical research, he actively contributes to trials aimed at developing innovative therapies for malignant haematology. His dedication to research ensures that his patients have access to cutting-edge advancements and novel treatment options close to home, fostering a reassuring and supportive environment for those under his care.